25 XP   0   0   10

Quantrx Biomedical
Buy, Hold or Sell?

Let's analyse Quantrx together

PenkeI guess you are interested in Quantrx Biomedical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Quantrx Biomedical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Quantrx Biomedical

I send you an email if I find something interesting about Quantrx Biomedical.

Quick analysis of Quantrx (30 sec.)










What can you expect buying and holding a share of Quantrx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.03
Expected worth in 1 year
$-0.05
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-330.4%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.004 - $0.004
How sure are you?
50%

1. Valuation of Quantrx (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.01 - $0.03

Total Value Per Share

$-0.04 - $-0.01

2. Growth of Quantrx (5 min.)




Is Quantrx growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.6m-$2.3m-$260k-9.8%

How much money is Quantrx making?

Current yearPrevious yearGrowGrow %
Making money-$476.7k-$469.4k-$7.2k-1.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Quantrx (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#169 / 173

Most Revenue
#170 / 173

Most Profit
#117 / 173

Most Efficient
#110 / 173

What can you expect buying and holding a share of Quantrx? (5 min.)

Welcome investor! Quantrx's management wants to use your money to grow the business. In return you get a share of Quantrx.

What can you expect buying and holding a share of Quantrx?

First you should know what it really means to hold a share of Quantrx. And how you can make/lose money.

Speculation

The Price per Share of Quantrx is $0.004. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Quantrx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Quantrx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.03. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Quantrx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-82.6%0.00-82.6%0.00-80.3%0.00-85.6%-0.01-130.8%
Usd Book Value Change Per Share0.00-82.6%0.00-82.6%0.00-80.3%0.00-61.2%0.00-88.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-82.6%0.00-82.6%0.00-80.3%0.00-61.2%0.00-88.2%
Usd Price Per Share0.01-0.01-0.01-0.01-0.02-
Price to Earnings Ratio-3.03--3.03--1.87--0.94--2.53-
Price-to-Total Gains Ratio-3.03--3.03--1.87--1.03--3.70-
Price to Book Ratio-0.30--0.30--0.20--0.37--1.67-
Price-to-Total Gains Ratio-3.03--3.03--1.87--1.03--3.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.004
Number of shares250000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (250000 shares)-826.09-611.59
Gains per Year (250000 shares)-3,304.37-2,446.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3304-33140-2446-2456
20-6609-66180-4893-4902
30-9913-99220-7339-7348
40-13217-132260-9785-9794
50-16522-165300-12232-12240
60-19826-198340-14678-14686
70-23131-231380-17124-17132
80-26435-264420-19571-19578
90-29739-297460-22017-22024
100-33044-330500-24464-24470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%2.026.00.07.1%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%8.019.01.028.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.028.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%8.019.01.028.6%

Fundamentals of Quantrx

About Quantrx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Fundamental data was last updated by Penke on 2024-03-12 13:58:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Quantrx Biomedical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Quantrx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Quantrx Biomedical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-34,446.5%+34,446.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-6.2%
TTM-7.4%-7.4%
YOY-8.0%-8.0%
5Y-7.1%-7.1%
10Y-34,446.5%7.7%-34,454.2%
1.1.2. Return on Assets

Shows how efficient Quantrx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • -8,011.8% Return on Assets means that Quantrx generated $-80.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Quantrx Biomedical:

  • The MRQ is -8,011.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8,011.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8,011.8%TTM-8,011.8%0.0%
TTM-8,011.8%YOY-847.0%-7,164.8%
TTM-8,011.8%5Y-1,904.0%-6,107.8%
5Y-1,904.0%10Y-1,024.8%-879.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,011.8%1.2%-8,013.0%
TTM-8,011.8%1.2%-8,013.0%
YOY-847.0%1.7%-848.7%
5Y-1,904.0%1.6%-1,905.6%
10Y-1,024.8%1.6%-1,026.4%
1.1.3. Return on Equity

Shows how efficient Quantrx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • 0.0% Return on Equity means Quantrx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Quantrx Biomedical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%-2.3%
TTM-2.6%-2.6%
YOY-3.1%-3.1%
5Y-3.2%-3.2%
10Y-3.0%-3.0%

1.2. Operating Efficiency of Quantrx Biomedical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Quantrx is operating .

  • Measures how much profit Quantrx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Quantrx Biomedical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-26,214.2%+26,214.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-8.4%
TTM-6.5%-6.5%
YOY-10.7%-10.7%
5Y-10.1%-10.1%
10Y-26,214.2%8.4%-26,222.6%
1.2.2. Operating Ratio

Measures how efficient Quantrx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y258.785-258.785
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.099-1.099
TTM-1.149-1.149
YOY-1.109-1.109
5Y-1.101-1.101
10Y258.7851.055+257.730

1.3. Liquidity of Quantrx Biomedical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Quantrx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.002. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.002. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.0020.000
TTM0.002YOY0.023-0.021
TTM0.0025Y0.135-0.133
5Y0.13510Y0.137-0.002
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0022.385-2.383
TTM0.0022.589-2.587
YOY0.0232.582-2.559
5Y0.1352.635-2.500
10Y0.1372.614-2.477
1.3.2. Quick Ratio

Measures if Quantrx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.0020.000
TTM0.002YOY0.023-0.021
TTM0.0025Y0.166-0.163
5Y0.16610Y0.138+0.028
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0021.165-1.163
TTM0.0021.172-1.170
YOY0.0231.283-1.260
5Y0.1661.392-1.226
10Y0.1381.477-1.339

1.4. Solvency of Quantrx Biomedical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Quantrx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Quantrx to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 444.88 means that Quantrx assets are financed with 44,488.2% credit (debt) and the remaining percentage (100% - 44,488.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Quantrx Biomedical:

  • The MRQ is 444.882. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 444.882. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ444.882TTM444.8820.000
TTM444.882YOY43.958+400.924
TTM444.8825Y102.093+342.789
5Y102.09310Y53.236+48.856
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ444.8820.353+444.529
TTM444.8820.355+444.527
YOY43.9580.358+43.600
5Y102.0930.362+101.731
10Y53.2360.369+52.867
1.4.2. Debt to Equity Ratio

Measures if Quantrx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.541-0.541
TTM-0.545-0.545
YOY-0.529-0.529
5Y-0.640-0.640
10Y-0.665-0.665

2. Market Valuation of Quantrx Biomedical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Quantrx generates.

  • Above 15 is considered overpriced but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -3.03 means the investor is paying $-3.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Quantrx Biomedical:

  • The EOD is -1.211. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.026. Based on the earnings, the company is expensive. -2
  • The TTM is -3.026. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.211MRQ-3.026+1.816
MRQ-3.026TTM-3.0260.000
TTM-3.026YOY-1.868-1.158
TTM-3.0265Y-0.936-2.091
5Y-0.93610Y-2.533+1.597
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-1.21117.039-18.250
MRQ-3.02617.929-20.955
TTM-3.02619.435-22.461
YOY-1.86820.661-22.529
5Y-0.93621.503-22.439
10Y-2.53327.130-29.663
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Quantrx Biomedical:

  • The EOD is -6.362. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.905. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.905. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.362MRQ-15.905+9.543
MRQ-15.905TTM-15.9050.000
TTM-15.905YOY-6.302-9.603
TTM-15.9055Y-5.960-9.946
5Y-5.96010Y-8.720+2.760
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-6.36210.083-16.445
MRQ-15.9059.744-25.649
TTM-15.9051.298-17.203
YOY-6.3024.667-10.969
5Y-5.9604.114-10.074
10Y-8.7200.108-8.828
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Quantrx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of -0.30 means the investor is paying $-0.30 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Quantrx Biomedical:

  • The EOD is -0.119. Based on the equity, the company is expensive. -2
  • The MRQ is -0.298. Based on the equity, the company is expensive. -2
  • The TTM is -0.298. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.119MRQ-0.298+0.179
MRQ-0.298TTM-0.2980.000
TTM-0.298YOY-0.198-0.100
TTM-0.2985Y-0.366+0.068
5Y-0.36610Y-1.673+1.306
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1192.522-2.641
MRQ-0.2982.733-3.031
TTM-0.2982.706-3.004
YOY-0.1983.220-3.418
5Y-0.3663.824-4.190
10Y-1.6734.219-5.892
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Quantrx Biomedical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%-0.003-3%-0.002-26%-0.004+7%
Book Value Per Share---0.034-0.0340%-0.030-10%-0.023-31%-0.018-45%
Current Ratio--0.0020.0020%0.023-90%0.135-98%0.137-98%
Debt To Asset Ratio--444.882444.8820%43.958+912%102.093+336%53.236+736%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.003-0.0030%-0.003-3%-0.003+4%-0.005+58%
Free Cash Flow Per Share---0.001-0.0010%-0.001+51%-0.002+169%-0.002+226%
Free Cash Flow To Equity Per Share---0.001-0.0010%-0.001+51%-0.002+174%-0.001+69%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.019-2%
Intrinsic Value_10Y_max--0.028--------
Intrinsic Value_10Y_min---0.011--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max--0.001--------
Intrinsic Value_3Y_min---0.005--------
Intrinsic Value_5Y_max--0.006--------
Intrinsic Value_5Y_min---0.007--------
Market Cap314785.984-150%786964.960786964.9600%472178.976+67%508004.519+55%1394314.487-44%
Net Profit Margin----0%-0%-0%-344.4650%
Operating Margin----0%-0%-0%-262.1420%
Operating Ratio----0%-0%-0%258.785-100%
Pb Ratio-0.119+60%-0.298-0.2980%-0.198-33%-0.366+23%-1.673+461%
Pe Ratio-1.211+60%-3.026-3.0260%-1.868-38%-0.936-69%-2.533-16%
Price Per Share0.004-150%0.0100.0100%0.006+67%0.006+77%0.017-42%
Price To Free Cash Flow Ratio-6.362+60%-15.905-15.9050%-6.302-60%-5.960-63%-8.720-45%
Price To Total Gains Ratio-1.211+60%-3.026-3.0260%-1.868-38%-1.027-66%-3.696+22%
Quick Ratio--0.0020.0020%0.023-90%0.166-99%0.138-98%
Return On Assets---80.118-80.1180%-8.470-89%-19.040-76%-10.248-87%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.003-0.0030%-0.003-3%-0.002-26%-0.004+7%
Usd Book Value---2641097.000-2641097.0000%-2381055.000-10%-1881285.000-29%-1480148.000-44%
Usd Book Value Change Per Share---0.003-0.0030%-0.003-3%-0.002-26%-0.004+7%
Usd Book Value Per Share---0.034-0.0340%-0.030-10%-0.023-31%-0.018-45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.0030%-0.003-3%-0.003+4%-0.005+58%
Usd Free Cash Flow---49478.000-49478.0000%-74923.000+51%-144921.400+193%-167464.700+238%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.001+51%-0.002+169%-0.002+226%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.001+51%-0.002+174%-0.001+69%
Usd Market Cap314785.984-150%786964.960786964.9600%472178.976+67%508004.519+55%1394314.487-44%
Usd Price Per Share0.004-150%0.0100.0100%0.006+67%0.006+77%0.017-42%
Usd Profit---476701.000-476701.0000%-469454.000-2%-326793.400-31%-440302.400-8%
Usd Revenue----0%-0%-0%2393.500-100%
Usd Total Gains Per Share---0.003-0.0030%-0.003-3%-0.002-26%-0.004+7%
 EOD+2 -6MRQTTM+0 -0YOY+11 -165Y+12 -1510Y+16 -14

3.2. Fundamental Score

Let's check the fundamental score of Quantrx Biomedical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.211
Price to Book Ratio (EOD)Between0-1-0.119
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.002
Current Ratio (MRQ)Greater than10.002
Debt to Asset Ratio (MRQ)Less than1444.882
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-80.118
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Quantrx Biomedical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.144
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.006
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.004
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6
Total Liabilities2,647
Total Stockholder Equity-2,641
 As reported
Total Liabilities 2,647
Total Stockholder Equity+ -2,641
Total Assets = 6

Assets

Total Assets6
Total Current Assets6
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 6
Total Current Assets  (as reported)6
Total Current Assets  (calculated)6
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,647
Long-term Liabilities2,647
Total Stockholder Equity-2,641
Total Current Liabilities
Short-term Debt 2,637
Short Long Term Debt 2,637
Accounts payable 10
Other Current Liabilities 10
Total Current Liabilities  (as reported)2,647
Total Current Liabilities  (calculated)5,294
+/- 2,647
Long-term Liabilities
Long-term Liabilities  (as reported)2,647
Long-term Liabilities  (calculated)0
+/- 2,647
Total Stockholder Equity
Common Stock787
Retained Earnings -52,375
Accumulated Other Comprehensive Income 9
Other Stockholders Equity 48,876
Total Stockholder Equity (as reported)-2,641
Total Stockholder Equity (calculated)-2,703
+/- 62
Other
Capital Stock849
Cash and Short Term Investments 6
Common Stock Shares Outstanding 78,696
Current Deferred Revenue-10
Liabilities and Stockholders Equity 6
Net Debt 2,631
Net Invested Capital -66
Net Tangible Assets -2,703
Net Working Capital -2,641
Short Long Term Debt Total 2,637



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-31
> Total Assets 
4,680
3,470
1,980
1,970
1,890
1,360
590
390
109
93
188
188
4,313
3,651
3,405
1,344
1,302
586
474
398
491
359
213
1,391
582
137
55
6
6551375821,3912133594913984745861,3021,3443,4053,6514,313188188931093905901,3601,8901,9701,9803,4704,680
   > Total Current Assets 
4,380
2,880
1,210
1,020
1,060
590
140
40
32
20
120
120
1,837
886
686
829
939
311
238
158
260
137
29
891
360
137
55
6
655137360891291372601582383119398296868861,8371201202032401405901,0601,0201,2102,8804,380
       Cash And Cash Equivalents 
3,920
2,460
670
530
670
430
10
10
32
20
108
108
1,257
213
66
376
230
8
10
4
219
61
1
460
322
130
55
6
6551303224601612194108230376662131,257108108203210104306705306702,4603,920
       Short-term Investments 
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
403
0
0
0
0
0000403000000000000000050000000
       Net Receivables 
0
0
30
60
60
10
30
20
0
0
0
0
461
296
277
320
682
284
202
121
0
0
0
0
0
0
0
0
00000000121202284682320277296461000020301060603000
       Inventory 
40
160
190
170
70
70
40
0
0
0
0
0
113
37
40
5
4
3
3
2
0
0
0
0
0
0
0
0
000000002334540371130000040707017019016040
       Other Current Assets 
420
260
320
260
260
80
10
10
0
0
12
1
5
112
113
128
23
17
23
30
41
76
28
28
38
7
0
0
007382828764130231723128113112511200101080260260320260420
   > Long-term Assets 
300
590
770
950
830
770
450
350
77
72
68
68
2,476
2,765
2,719
514
362
275
236
240
231
221
184
500
222
0
0
0
0002225001842212312402362753625142,7192,7652,47668687277350450770830950770590300
       Property Plant Equipment 
160
450
620
820
710
650
360
270
0
0
0
10
157
392
496
180
109
35
4
3
2
1
0
0
0
0
0
0
00000012343510918049639215710000270360650710820620450160
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
200
170
500
222
0
0
0
0002225001702002002000000000000000000000
       Intangible Assets 
30
20
30
60
60
60
80
80
77
72
68
68
114
2,162
2,012
60
47
39
32
37
29
20
14
14
0
0
0
0
00001414202937323947602,0122,162114686872778080606060302030
       Long-term Assets Other 
110
120
120
70
60
60
10
0
0
0
0
10
2,206
211
211
11
6
35
4
3
0
1
184
500
222
0
0
0
0002225001841034356112112112,20610000010606070120120110
> Total Liabilities 
2,230
280
1,210
1,240
1,150
720
780
1,270
1,092
1,122
722
722
746
1,812
6,536
1,365
846
451
854
1,088
1,705
1,791
1,891
2,140
2,088
2,266
2,436
2,647
2,6472,4362,2662,0882,1401,8911,7911,7051,0888544518461,3656,5361,8127467227221,1221,0921,2707807201,1501,2401,2102802,230
   > Total Current Liabilities 
2,230
280
1,020
1,010
1,110
270
780
1,270
1,092
1,122
722
722
370
1,762
6,492
1,321
802
407
810
1,044
1,661
1,751
1,855
2,140
2,088
2,266
2,436
2,647
2,6472,4362,2662,0882,1401,8551,7511,6611,0448104078021,3216,4921,7623707227221,1221,0921,2707802701,1101,0101,0202802,230
       Short-term Debt 
2,000
0
0
0
420
0
400
400
453
453
453
453
0
806
3,927
233
0
168
418
739
1,156
1,312
1,658
1,946
2,006
2,203
2,420
2,637
2,6372,4202,2032,0061,9461,6581,3121,15673941816802333,927806045345345345340040004200002,000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
783
2
2
1,658
1,946
2,006
1,539
1,554
2,637
2,6371,5541,5392,0061,9461,658227830000000000000000000
       Accounts payable 
180
200
250
530
300
60
150
390
201
231
146
146
245
720
2,206
749
632
223
375
285
462
405
161
168
56
62
16
10
101662561681614054622853752236327492,20672024514614623120139015060300530250200180
       Other Current Liabilities 
50
80
770
480
390
210
230
480
439
439
123
123
42
2
301
2
170
16
17
20
43
34
36
27
26
776
947
10
10947776262736344320171617023012421231234394394802302103904807708050
   > Long-term Liabilities 
0
0
190
230
40
450
0
0
0
0
0
0
377
50
44
44
44
44
44
44
44
39
36
36
0
14
2,436
2,647
2,6472,43614036363944444444444444503770000004504023019000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
44
39
36
0
0
0
0
0
00000363944440000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
377
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000377000000000000
> Total Stockholder Equity
2,450
3,190
770
730
740
640
-190
-890
-983
-1,030
-534
-534
3,566
1,839
-3,132
-22
456
135
-380
-690
-1,215
-1,432
-1,678
-750
-1,506
-2,128
-2,381
-2,641
-2,641-2,381-2,128-1,506-750-1,678-1,432-1,215-690-380135456-22-3,1321,8393,566-534-534-1,030-983-890-1906407407307703,1902,450
   Common Stock
70
90
100
130
100
100
100
100
107
107
139
139
374
417
429
444
444
632
608
647
696
698
787
787
787
787
787
787
7877877877877877876986966476086324444444294173741391391071071001001001001301009070
   Retained Earnings -52,375-52,115-51,862-51,240-50,503-51,373-50,975-50,507-49,680-49,322-48,604-47,820-48,263-45,110-37,388-30,514-21,729-21,729-21,709-21,663-21,540-20,670-18,850-16,360-11,730-9,740-5,400-1,210
   Accumulated Other Comprehensive Income 
-10
-100
-240
-370
-520
-640
-680
-720
0
0
0
-2
-16
-101
-199
-219
-247
-160
-29
-30
0
-32
-34
-34
0
9
9
9
9990-34-34-320-30-29-160-247-219-199-101-16-2000-720-680-640-520-370-240-100-10
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,139
48,429
48,678
48,740
48,792
48,876
48,876
48,876
0
048,87648,87648,87648,79248,74048,67848,42948,1390000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
3,600
8,600
10,650
12,700
17,520
20,030
21,060
21,270
20,498
20,498
20,981
20,981
33,722
38,911
41,748
47,975
47,899
48,062
48,159
48,169
48,429
48,710
48,774
48,834
48,885
48,876
48,876
48,876
48,87648,87648,87648,88548,83448,77448,71048,42948,16948,15948,06247,89947,97541,74838,91133,72220,98120,98120,49820,49821,27021,06020,03017,52012,70010,6508,6003,600



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-43
Operating Income-43-43
 
Operating Expense (+$)
Research Development0
Selling General Administrative43
Selling And Marketing Expenses0
Operating Expense4343
 
Net Interest Income (+$)
Interest Income0
Interest Expense-217
Other Finance Cost-0
Net Interest Income-217
 
Pretax Income (+$)
Operating Income-43
Net Interest Income-217
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-260173
EBIT - interestExpense = -260
-260
-260
Interest Expense217
Earnings Before Interest and Taxes (EBIT)-43-43
Earnings Before Interest and Taxes (EBITDA)-43
 
After tax Income (+$)
Income Before Tax-260
Tax Provision-0
Net Income From Continuing Ops-260-260
Net Income-477
Net Income Applicable To Common Shares-260
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43
Total Other Income/Expenses Net-217217
 

Technical Analysis of Quantrx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Quantrx. The general trend of Quantrx is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Quantrx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Quantrx Biomedical.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.004 < 0.004 < 0.004.

The bearish price targets are: 0.004 > 0.004 > 0.004.

Tweet this
Quantrx Biomedical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Quantrx Biomedical. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Quantrx Biomedical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Quantrx Biomedical. The current macd is -0.00045238.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quantrx price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Quantrx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Quantrx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Quantrx Biomedical Daily Moving Average Convergence/Divergence (MACD) ChartQuantrx Biomedical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Quantrx Biomedical. The current adx is 89.28.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Quantrx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Quantrx Biomedical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Quantrx Biomedical. The current sar is 0.00540555.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Quantrx Biomedical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Quantrx Biomedical. The current rsi is 0.14433592. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Quantrx Biomedical Daily Relative Strength Index (RSI) ChartQuantrx Biomedical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Quantrx Biomedical. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Quantrx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Quantrx Biomedical Daily Stochastic Oscillator ChartQuantrx Biomedical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Quantrx Biomedical. The current cci is -66.66666667.

Quantrx Biomedical Daily Commodity Channel Index (CCI) ChartQuantrx Biomedical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Quantrx Biomedical. The current cmo is -99.99657129.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Quantrx Biomedical Daily Chande Momentum Oscillator (CMO) ChartQuantrx Biomedical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Quantrx Biomedical. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Quantrx Biomedical Daily Williams %R ChartQuantrx Biomedical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Quantrx Biomedical.

Quantrx Biomedical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Quantrx Biomedical. The current atr is 0.000042.

Quantrx Biomedical Daily Average True Range (ATR) ChartQuantrx Biomedical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Quantrx Biomedical. The current obv is -1,575,009.

Quantrx Biomedical Daily On-Balance Volume (OBV) ChartQuantrx Biomedical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Quantrx Biomedical. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Quantrx Biomedical Daily Money Flow Index (MFI) ChartQuantrx Biomedical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Quantrx Biomedical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Quantrx Biomedical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Quantrx Biomedical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.144
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.006
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.004
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Quantrx with someone you think should read this too:
  • Are you bullish or bearish on Quantrx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Quantrx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Quantrx Biomedical

I send you an email if I find something interesting about Quantrx Biomedical.


Comments

How you think about this?

Leave a comment

Stay informed about Quantrx Biomedical.

Receive notifications about Quantrx Biomedical in your mailbox!